AP9701148A0 - Dimesylate salts of neuropeptide Y ligands. - Google Patents
Dimesylate salts of neuropeptide Y ligands.Info
- Publication number
- AP9701148A0 AP9701148A0 APAP/P/1997/001148A AP9701148A AP9701148A0 AP 9701148 A0 AP9701148 A0 AP 9701148A0 AP 9701148 A AP9701148 A AP 9701148A AP 9701148 A0 AP9701148 A0 AP 9701148A0
- Authority
- AP
- ARIPO
- Prior art keywords
- neuropeptide
- ligands
- dimesylate
- salts
- dimesylate salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3181596P | 1996-11-26 | 1996-11-26 | |
| PCT/IB1997/001465 WO1998023603A1 (en) | 1996-11-26 | 1997-11-19 | Dimesylate salts of neuropeptide y ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP9701148A0 true AP9701148A0 (en) | 1998-01-31 |
Family
ID=21861551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1997/001148A AP9701148A0 (en) | 1996-11-26 | 1997-11-20 | Dimesylate salts of neuropeptide Y ligands. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5914329A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0944611B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3120861B2 (cg-RX-API-DMAC7.html) |
| AP (1) | AP9701148A0 (cg-RX-API-DMAC7.html) |
| AR (1) | AR010304A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE257472T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU4792497A (cg-RX-API-DMAC7.html) |
| BR (1) | BR9713538A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2272927C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69727155T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0944611T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2213207T3 (cg-RX-API-DMAC7.html) |
| GT (1) | GT199700123A (cg-RX-API-DMAC7.html) |
| HN (1) | HN1997000154A (cg-RX-API-DMAC7.html) |
| HR (1) | HRP970640A2 (cg-RX-API-DMAC7.html) |
| ID (1) | ID18964A (cg-RX-API-DMAC7.html) |
| MA (1) | MA26450A1 (cg-RX-API-DMAC7.html) |
| PA (1) | PA8441701A1 (cg-RX-API-DMAC7.html) |
| PE (1) | PE17099A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT944611E (cg-RX-API-DMAC7.html) |
| TN (1) | TNSN97191A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998023603A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA9710587B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001053477A1 (en) * | 2000-01-20 | 2001-07-26 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
| EP2002827A2 (en) | 2001-12-05 | 2008-12-17 | The Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of sympathetic tone |
| WO2003057886A2 (en) | 2002-01-09 | 2003-07-17 | Arexis Ab | Detection of mutations |
| KR100716389B1 (ko) * | 2004-11-23 | 2007-05-11 | 동화약품공업주식회사 | Ｎ-히드록시－４－｛５－［４－（5－이소프로필－２－메틸－１,３－티아졸－4－일）페녹시］펜톡시｝벤즈아미딘 ２메탄술폰산염 |
| EP1877076A4 (en) * | 2005-04-15 | 2012-02-01 | Regenertech Pty Ltd | USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996014307A1 (en) * | 1994-11-07 | 1996-05-17 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
-
1997
- 1997-11-18 US US08/972,470 patent/US5914329A/en not_active Expired - Fee Related
- 1997-11-18 PA PA19978441701A patent/PA8441701A1/es unknown
- 1997-11-19 CA CA002272927A patent/CA2272927C/en not_active Expired - Fee Related
- 1997-11-19 EP EP97910602A patent/EP0944611B1/en not_active Expired - Lifetime
- 1997-11-19 BR BR9713538A patent/BR9713538A/pt not_active Application Discontinuation
- 1997-11-19 AT AT97910602T patent/ATE257472T1/de not_active IP Right Cessation
- 1997-11-19 ES ES97910602T patent/ES2213207T3/es not_active Expired - Lifetime
- 1997-11-19 DK DK97910602T patent/DK0944611T3/da active
- 1997-11-19 PT PT97910602T patent/PT944611E/pt unknown
- 1997-11-19 WO PCT/IB1997/001465 patent/WO1998023603A1/en not_active Ceased
- 1997-11-19 DE DE69727155T patent/DE69727155T2/de not_active Expired - Fee Related
- 1997-11-19 JP JP10524469A patent/JP3120861B2/ja not_active Expired - Fee Related
- 1997-11-19 AU AU47924/97A patent/AU4792497A/en not_active Abandoned
- 1997-11-19 PE PE1997001052A patent/PE17099A1/es not_active Application Discontinuation
- 1997-11-20 AP APAP/P/1997/001148A patent/AP9701148A0/en unknown
- 1997-11-24 AR ARP970105494A patent/AR010304A1/es unknown
- 1997-11-25 ID IDP973762A patent/ID18964A/id unknown
- 1997-11-25 TN TNTNSN97191A patent/TNSN97191A1/fr unknown
- 1997-11-25 MA MA24872A patent/MA26450A1/fr unknown
- 1997-11-25 GT GT199700123A patent/GT199700123A/es unknown
- 1997-11-25 ZA ZA9710587A patent/ZA9710587B/xx unknown
- 1997-11-26 HN HN1997000154A patent/HN1997000154A/es unknown
- 1997-11-26 HR HR60/031,815A patent/HRP970640A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69727155D1 (de) | 2004-02-12 |
| DK0944611T3 (da) | 2004-04-13 |
| US5914329A (en) | 1999-06-22 |
| DE69727155T2 (de) | 2004-07-08 |
| HRP970640A2 (en) | 1998-10-31 |
| EP0944611A1 (en) | 1999-09-29 |
| CA2272927A1 (en) | 1998-06-04 |
| JP3120861B2 (ja) | 2000-12-25 |
| ID18964A (id) | 1998-05-28 |
| WO1998023603A1 (en) | 1998-06-04 |
| CA2272927C (en) | 2003-02-04 |
| PE17099A1 (es) | 1999-02-19 |
| GT199700123A (es) | 1999-05-19 |
| ZA9710587B (en) | 1999-05-25 |
| ES2213207T3 (es) | 2004-08-16 |
| PT944611E (pt) | 2004-04-30 |
| MA26450A1 (fr) | 2004-12-20 |
| HN1997000154A (es) | 1999-02-09 |
| TNSN97191A1 (fr) | 2005-03-15 |
| AR010304A1 (es) | 2000-06-07 |
| JP2000505110A (ja) | 2000-04-25 |
| BR9713538A (cg-RX-API-DMAC7.html) | 2000-03-21 |
| EP0944611B1 (en) | 2004-01-07 |
| PA8441701A1 (es) | 2000-05-24 |
| ATE257472T1 (de) | 2004-01-15 |
| AU4792497A (en) | 1998-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9602721D0 (en) | Use of serotonin antagonists (5ht3) for treating fibromyalgia | |
| NO970162L (no) | Substituerte pyrimidinforbindelser og anvendelse derav | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| DE69526206D1 (de) | Verwendung von interleukin-12 fuer die verhinderung von transplantat gegen empfaengerkrankheit | |
| BG101112A (bg) | Използване на хетероциклени съединения | |
| BG104996A (en) | Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation | |
| ES2127744T3 (es) | Vendaje de cinta y metodo para su produccion. | |
| DE69534908D1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| FI913142A0 (fi) | Migraenfoerhindrande alkoxipyrimidinderivat. | |
| UA66793C2 (uk) | Лептин як стримувач швидкого збільшення пухлини клітини | |
| ATE242234T1 (de) | Bicyclische arylcarboxamide und ihre therapeutische verwendung | |
| ATE210447T1 (de) | Verwendung von cck-b rezeptor antagonisten zur behandlung von schlafstörungen | |
| ATE283272T1 (de) | Morphine derivate mit analgetischen eigenschaften | |
| SI1242410T1 (en) | Novel compounds | |
| FI971127A7 (fi) | 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollagee nin kypsymis- ja rakentumishäiriöiden hoitamiseen | |
| CA2272927A1 (en) | Dimesylate salts of neuropeptide y ligands | |
| ID23175A (id) | Penggunaan benzopiranol untuk mengobati gangguan syaraf | |
| PT828851E (pt) | Inibidores de tripeptidilpeptidase | |
| DE69518438D1 (de) | Behandlung von übereregten nervenzellenfunktionen | |
| ZA931099B (en) | Heterocyclic compounds their use and preparation | |
| AP2000001963A0 (en) | Paroxetine ascorbate. | |
| FI965171L (fi) | Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö kasvainten hoidossa sivuvaikutuksien vähentämiseksi | |
| DE69302250D1 (de) | Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia | |
| ATE74755T1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
| ECSP972321A (es) | Sales dimesilato de los ligandos del neuropeptido y antecedentes de la invencion |